• Home
  • About Us
    • Our Mission
    • Management
    • Board of Directors
    • Advisory Board
    • Our Team
  • Our Science
    • Ionic Liquid Platform
    • Clinical Focus
    • Clinical Results
  • Career
  • More
    • Clinical Trials
    • Press Releases
    • In the News
    • Publications
  • Contact Us
  • More
    • Home
    • About Us
      • Our Mission
      • Management
      • Board of Directors
      • Advisory Board
      • Our Team
    • Our Science
      • Ionic Liquid Platform
      • Clinical Focus
      • Clinical Results
    • Career
    • More
      • Clinical Trials
      • Press Releases
      • In the News
      • Publications
    • Contact Us
  • Home
  • About Us
    • Our Mission
    • Management
    • Board of Directors
    • Advisory Board
    • Our Team
  • Our Science
    • Ionic Liquid Platform
    • Clinical Focus
    • Clinical Results
  • Career
  • More
    • Clinical Trials
    • Press Releases
    • In the News
    • Publications
  • Contact Us
Doctor reviewing medical documents with blue gloves.

Clinical Trials

Developing effective localized treatments, such as those explored in an atopic dermatitis study, to address unmet needs across a number of skin conditions, including the use of topical DNA aptamer therapy.

Multicenter, randomized double-blind, vehicle-controlled Phase 2a study for “Atopic Dermatitis”

STUDY IDENTIFIER

NCT05487963

Multicenter, randomized double-blind, vehicle-controlled Phase 2b study for “Atopic Dermatitis”

STUDY IDENTIFIER

NCT06810050


Copyright © 2026 CAGE Bio Inc. - All Rights Reserved.

Powered by

  • Board of Directors
  • Our Team
  • Career
  • Contact Us

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

DeclineAccept